NATCO launches anticoagulant drug Rivaroxaban in India Ruchika Sharma18 Dec 2020 12:00 PM ISTHyderabad: Natco Pharma Limited has recently announced the launch of Rivaroxaban molecule, under brand RPIGAT. Rivaroxaban is an anticoagulant...
Natco Pharma Pomalidomide capsules get USFDA okay Ruchika Sharma16 Nov 2020 10:00 AM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company's marketing partner, Breckenridge Pharmaceutical Inc., has...
Natco Pharma net profit rises 73 percent to Rs 204 crore in Q2 Ruchika Sharma15 Nov 2020 11:00 AM ISTNew Delhi: Drug firm Natco Pharma on Thursday reported a 73.23 percent increase in its consolidated net profit to Rs 203.9 crore for the quarter ended...
Natco Pharma to launch 10 new products in India in near term Ruchika Sharma16 Oct 2020 11:30 AM ISTHyderabad: Natco Pharma aims to launch around 10 new products every year in the Indian market, the city-based drug maker said on Thursday. "Our...
Intellectual Property Apellate Board stays cancellation of Novartis patent for Anti-Cancer Drug Ceritinib Farhat Nasim5 Oct 2020 3:33 PM ISTNew Delhi: The Intellectual Property Apellate Board (IPAB) has recently stayed the cancellation of the Swiss drugmaker Novartis' patent over the...
Natco Pharma to launch new products in non-oncology segment Ruchika Sharma22 Sept 2020 11:00 AM ISTNew Delhi: Natco Pharma plans to diversify its product portfolio in the domestic market as it aims to make up for a drop in business of some of its...
Natco Pharma, Celgene ink pact for cancer treatment drug Lenalidomide Ruchika Sharma11 July 2020 12:47 PM ISTLenalidomide is used to treat various types of cancers.
